Stephen Krause

The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

Michael S. Rafii, Reisa A. Sperling, Michael Donohue et al. · Alzheimer s & Dementia · 2022 · 230 citations · Full text

Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: A head-to-head comparison with alendronate

Donald S. Williams, Paul J. McCracken, Mona Purcell et al. · Bone · 2013 · 37 citations

Bone Turnover Markers, Ovariectomized Monkeys, Bone Health +8

Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A–Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity

Shil Patel, Ashley C. Knight, Stephen Krause et al. · Molecular Imaging and Biology · 2019 · 35 citations

Synapse Integrity, Synaptic Plasticity, Engineering +14

Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects—a MissionAD tau sub-study

Santiago Bullich, André Mueller, Susan De Santi et al. · Alzheimer s Research & Therapy · 2022 · 28 citations · Full text

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)

Paul Aisen, Jin Zhou, Michael C. Irizarry et al. · Alzheimer s & Dementia · 2020 · 23 citations · Full text

Amyloid Pet, Geriatric Neurology, Neurobiology Of Disease +21